Evidence map›Paper›PMID 27677368›Full record

Trial reportEuropean journal of clinical nutrition2017

Corn oil intake favorably impacts lipoprotein cholesterol, apolipoprotein and lipoprotein particle levels compared with extra-virgin olive oil.

K C Maki, A L Lawless, K M Kelley, V N Kaden, C J Geiger, O M Palacios, M R Dicklin

Open access · bronzeAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of clinical nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

K C MakiMidwest Biomedical - Center for Metabolic and Cardiovascular Research, Glen Ellyn, IL, USA.
A L LawlessBiofortis Innovation Services/Merieux NutriSciences, Addison, IL, USA.
K M KelleyBiofortis Innovation Services/Merieux NutriSciences, Addison, IL, USA.
V N KadenBiofortis Innovation Services/Merieux NutriSciences, Addison, IL, USA.
C J GeigerGeiger and Associates, LLC, Fort Bridger, WY, USA.
O M PalaciosMidwest Biomedical - Center for Metabolic and Cardiovascular Research, Glen Ellyn, IL, USA.
M R DicklinMidwest Biomedical - Center for Metabolic and Cardiovascular Research, Glen Ellyn, IL, USA.
MB Clinical Research and Consulting (United States) · USReinhart & Associates (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCorn oil (CO) and extra-virgin olive oil (EVOO) are rich sources of unsaturated fatty acids (UFA), but UFA profiles differ among oils, which may affect lipoprotein levels.

objectivesThe objective of this study was to assess the effects of CO versus EVOO intake on fasting lipoprotein and subfraction cholesterol levels, apolipoprotein (apo) A1, apo B, and low-density lipoprotein particle concentrations in men and women. SUBJECTS/

methodsAs part of a weight maintenance diet, men and women were provided with food items prepared with 54 g per day of CO or EVOO (21-day treatment, 21-day washout) in a randomized, double-blind, controlled-feeding, crossover trial. Fasting lipoprotein cholesterol and related variables were determined with density gradient ultracentrifugation.

resultsAmong the 54 completers, CO reduced total cholesterol, low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), apo B and LDL particle concentration to a greater extent compared with EVOO intake. Changes in LDL-C and VLDL-C contributed to the larger reduction in non-HDL-C with CO compared with EVOO intake (-0.39 mmol/l vs -0.04 mmol/l; P<0.001). The larger reduction in LDL-C by CO intake was attributable to changes (P<0.05) caused by CO vs EVOO in large LDL

conclusionsCO intake reduced atherogenic lipoprotein cholesterol and particle concentrations to a larger extent than did EVOO, which may have implications for cardiovascular disease risk.

Indexed as

Apolipoprotein A-IApolipoproteinsApolipoproteins BCholesterolCorn OilCross-Over StudiesDouble-Blind MethodEatingFemaleHumansLipoproteinsLipoproteins, LDLMaleMiddle AgedOlive OilAPOA1 protein, humanApolipoprotein A-IApolipoproteinsApolipoproteins BCholesterolCorn Oillipoprotein cholesterolLipoproteinsLipoproteins, LDLOlive Oil

Identifiers

PMID27677368
OpenAlexW2525012812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.